Article
Study of MDM2 binding to p53-analogues: affinity, helicity, and applicability to drug design.
Journal of chemical information and modeling - 1 Apr 2009
Kalid Ori, Ben-Tal Nir
Abstract excerpt
MDM2 is a key regulator of the p53 tumor-suppressor protein. Here we study the effect of modifications of a p53 N-terminal fragment on its binding to MDM2, using implicit-solvent MD and MM-GB/SA calculations. We provide interpretation of existing experimental data and predict the effect of mutations on binding. Notably 1) We analyze the effect of regulatory phosphorylations at Ser/Thr residues and suggest that a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
